*Corresponding Author:
Nesy Ea
Department of Botany,
Kodungallur Kunhikuttan Thampuran Memorial Government College,
Pullut, Thrissur,
Kerala 680663,
E-mail: nesyiby@yahoo.in
Date of Received 26 February 2020
Date of Revision 03 August 2021
Date of Acceptance 03 October 2021
Indian J Pharm Sci 2021;83(5):1000-1006  

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms


Thevetia peruviana seed kernels are widely used for suicide attempts in many countries including India. The aim of the present study was to evaluate the level of toxicity exposure of seed kernels by acute and subacute studies on male Wistar albino rats. Haematological parameters and serum biochemical studies were performed in all treated and control groups. In acute toxicity studies, no mortality was observed in groups treated with 100 and 250 mg/kg animals, but the mortality rate was 100 % in 500 mg/kg category. Lethality (lethal dose 50 %) associated with 70 % methanol extract was calculated as 375 mg/kg, revealed the narrow margin of safety lies in between 250 and 500 mg/kg. Exposure to subacute doses did not make any significant changes (p>0.05) in physical parameters like body weight and feeding habits of all treated groups (25, 50 and 100 mg/kg for consecutive 14 d). All groups recorded a progressive weight gain and normal food consumption and water intake (p>0.05) as compared with control. Total erythrocytes, haemoglobin concentration, lipid profile, serum electrolytes, bicarbonates, liver functioning enzymes, total protein, albumin, bilirubin, renal urea and creatinine levels were recorded normal in acute and subacute groups. From this experiment it is concluded that the level of toxicity and safety margin is very narrow and the seeds really take lives of organisms, whether the intake is accidental or deliberate.


Thevetia peruviana seed kernels, lethal dose, haemogram profile, renal profile, lipid profile, serum electrolytes

Herbs and herbal preparations have played a vital role in health and disease management for centuries. As medicinal plants contain complex mixtures of many bioactive principles, it is difficult to map out all the unraveled interactions and synergies that may take place between them, the safety of herbal medicines cannot be guaranteed [1]. Hence, it will be worth to analyze the side effects of any crude preparation before enlisting as a source of herbal remedy.

Most members of family Apocynaceae are enlisted as medicinal as well as toxic plants because of the narrow margin of safety between therapeutic and toxic doses that the cardiac glycosides encompass. Digoxin, an irreplaceable drug for heart diseases isolated from the fermented foliage of foxglove (Digitalis lanata) is found in a mixture of secondary glycosides, which has not been synthesized yet because of its complex structure [2]. Moreover, these plant derived cardiac drugs have no alternatives to conventional medicines [3]. The term cardiac glycosides are commonly used to represent a wide variety of steroid derivatives that have the property of increasing the force of myocardial contraction and felicitating characteristic electro-physiological effect on the heart [4]. The investigating taxon Thevetia peruviana is considered as a therapeutically significant cardioactive plant with toxicological properties like Digitalis.

Despite the toxicity, whole plant and various plant parts like bark, leaves, roots and seeds have been used as cathartic, emetic, diuretic, febrifuge and purgative [5,6] to cure bladder stones, dropsy, edema, intermitted fevers, haemorrhoids, insomnia, tumors, rheumatism and ulcers [7,8], besides its potential role in healing acne, constipation, nausea, cardiac disorders, fever and measles.

For the safe use of medicinal plants, an evaluation of its toxicity is essential. The prime task of toxicological evaluation of any herbal medicine is to identify the nature and significance of adverse effects and to determine the limits of exposure level where the effect is observed [3]. This test measures the relative toxicological response of an experimental organism to single or brief exposure to a test substance [9]. Subacute oral toxicity studies of herbal medicines are essential to identify the safety and to determine the dose levels that could be useful afterwards [10].

In India and Sri Lanka, deliberate seed intake of ‘yellow oleander’ with suicidal and homicidal purpose and as an abortifacient was in usual practice [8,11]. Also, the exposure of yellow oleander poisoning cases in humans with various clinical complications like vomiting, diarrhea, arrhythmias and palpitation are widely discussed [12-14]. Hence, the present work was carried out to explore the toxic exposure levels and related metabolic abnormalities in essential organs at primary level taking Wistar rat as an animal model.

Materials and Methods


Male Wistar albino rats with an average body weight of 45-50 g were procured from the Small Animal Breeding Station (SABS), Kerala Veterinary and Animal Sciences University, Mannuthy, Kerala, India and maintained under standard environmental conditions in the animal house of Amala Cancer Research Centre, Trichur. During the acclimatization period of 4 w, rats were fed with ad libitum access to standard pellet diet and tap water in graduated bottles. They were divided into various groups for acute and subacute studies, after attaining 170-190 g body weight. All animal experiments were conducted as per Organization for Economic Co-operation and Development (OECD) guidelines (423) and with prior permission of the Institutional Animal Ethics Committee (IAEC) of the Research Centre, approved by Government of India.

Preparation of drug samples:

Approximately 60 g coarsely powdered seed kernels of yellow oleander were de-fatted with petroleum ether and extracted using 70 % Methanol (MT) in a soxhlet extractor for 20-22 h. The residue was collected, evaporated off the solvent and stored in airtight bottles at 4o, for toxicity studies.

Acute toxicity study:

Twenty male Wistar rats of an average body weight (182 g) were divided into four groups of five each and were given a single oral dose of the seed extract (Table 1). All animals were fasted for 2-3 h before and after drug administration. They were observed continuously for the first 6 h for any behavioral and clinical changes, followed by 72 h monitoring of mortality rates. Body weight, food consumption and water intake were recorded for a period of 14 d. Lethal dose 50 % (LD50) was calculated using the arithmetic method of Karbar, modified by Alui and Nwude [15] using the formula LD50=LD100-(Dd×Md)/N; where LD100=Dose that caused 100 % mortality; N=Number of animals per group; Dd×Md=Dose difference (Dd) multiplied by mean death (Md).

Group Acute toxicity doses Subacute toxicity doses
I Control (1 ml vehicle) Control
II 100 mg/kg body weight 25 mg/kg body weight
III 250 mg/kg body weight 50 mg/kg body weight
IV 500 mg/kg body weight 100 mg/kg body weight

Table 1: Groups of Animals For Acute And Subacute Studies

Subacute toxicity study:

After determining LD50 level of the extract, subacute studies were conducted in adult rats, in four groups of five each.

All animals were given oral doses of drugs for consecutive 14 d, with simultaneous observation of clinical changes, weight loss, behavioral changes and feeding habits. On 15th d animals were sacrificed and blood samples were collected in heparinised and non-heparinised vials for haematological and serum biochemical studies. Vital internal organs such as liver, kidney, heart and brain were dissected out, observed visually for any necrotic lesions, washed in chilled phosphate buffered saline (PBS), blotted dry and weighed. All tissue samples and plasma were stored at -80o for further analyses.

Haematological parameters viz. haemoglobin concentration, total erythrocyte, differential leukocyte and platelet counts were analyzed using a Hitachi blood cell counter. Blood samples collected in nonheparinised tubes were allowed to clot, centrifuged at 3000 rpm for 5 min. Separated serum was collected in 1.5 ml Eppendorf tubes and stored in -20o to perform biochemical assays like lipid profile, serum electrolytes, Bicarbonates (HCO3), liver functioning enzymes such as Serum Glutamic Oxaloacetic Transaminase (SGOT), Serum Glutamic Pyruvic Transaminase (SGPT), Alkaline Phosphatase (ALP), total protein, albumin, bilirubin, renal urea and creatinine levels by standard diagnostic kits with the aid of the Hitachi-902 Automatic Biochemistry Analyzer.

Analysis of data:

The results are expressed as mean values±Standard Deviation (SD). One way Analysis of Variance (ANOVA) with post-hoc Tukey’s Honest Significant Difference (HSD) test was used to compare significant differences between group means, using Statistical Package for the Social Sciences (SPSS) software version 20 (2012). A level of p<0.05 was regarded as statistically significant.

Results and Discussion

Experimental animal models have been successfully utilized to evaluate various treatment protocols intended to manage toxic oleander exposures. In acute toxicity studies, no mortality was observed in Group I (Control), Group II (100 mg/kg) and Group III (250 mg/ kg) animals, but the mortality rate was 100 % in Group IV (500 mg/kg) category (Table 2). These animals died within 10-12 h of drug administration with severe, marked clinical manifestations such as abnormal sweating, disorientation, paralysis and rolling of the body. An LD50 of 375 mg/kg was calculated which indicated a narrow safety margin when compared with the preceding group (250 mg/kg).

Groups Dose (mg/kg body weight) Dd No. of animals/group (N) Mortality (Death/Survival) Md
Group I 0 (Control) 0 5 0 0
Group II 100 100 5 0 0
Group III 250 150 5 0 0
Group IV 500 250 5 5/5 5
    500     1.25

Table 2: Acute Toxicity (Ld50) Studies in Wistar Rats Showing Survival/Mortality Rates

A significant decrease (p<0.01) in average body weight in 250 mg/kg treated group and a slow weight gain (5 %) in 100 mg/kg group was observed against the normal weight gain (10 %) in the control group during 2 w of observation. Similarly, 250 mg/kg treated group showed a decrease in food consumption (p<0.01) and water intake (p<0.001), but 100 mg/kg group showed no significant changes (p>0.05) when compared to the untreated group (Table 3). There was a strong, positive correlation between body weight, food consumption (p<0.05) and water intake (p<0.01) in group IV animals.

Treatments d 0 d 3 d 6 d 9 d 12 d 15
Body weight (g)
Control 150.67±15.14 161.00±13.42 182.00±10.43 191.22±8.97 198.11±3.66 200.17±4.49
25 mg/kg 159.80±3.56 172.00±6.01 184.20±11.22 200.13±10.61 205.07±12.52 217.40±14.12
50 mg/kg 158.40±6.31 173.60±14.14 190.20±10.74 207.73±7.64 220.73±5.69 230.70±4.42
100 mg/kg 187.40±9.32 194.47±10.56 207.00±11.27 223.47±9.39 234.93±13.43 241.40±16.30
Food intake (g)
Control 105.83±8.25 108.33±11.67 108.89±14.17 90.00±10.93 83.33±8.33 121.67±2.36
25 mg/kg 101.00±1.41 107.33±32.35 112.33±32.33 105.67±8.14 98.33±5.77 135.50±17.68
50 mg/kg 74.00±5.66 84.00±38.51 113.33±10.54 112.67±3.21 109.00±4.58 123.50±27.58
100 mg/kg 108.00±11.31 125.67±3.79 123.67±4.73 113.00±10.44 102.67±6.81 119.00±21.21
Water intake (ml)
Control 91.67±0.00 115.56±20.84 97.2±29.62 94.44±12.73 86.11±4.81 100.00±23.57
25 mg/kg 85.00±0.00 83.33±22.55 111.67±33.29 101.67±2.89 131.67±18.93 100.00±0.00
50 mg/kg 30.00±0.00 56.67±40.41 113.33±35.12 118.33±11.55 106.67±40.41 95.00±35.36
100 mg/kg 105.00±21.21 85.00±13.23 103.33±22.55 113.33±18.03 106.67±30.55 102.50±10.61

Table 3: Effect of Seed Extract On Body Weight and Feeding Habits In Wistar Rats During Subacute Studies

LD50= LD100-(Dd×Md)/N

Where LD100=500; N=5; Dd×Md=500×1.25


=375 mg/kg body weight

Exposure to subacute doses did not make any significant changes (p>0.05) in physical parameters like body weight and feeding habits of all treated groups against the control group. All groups recorded a progressive weight gain, normal food consumption and water intake (p>0.05) as compared with control, recorded on every 3rd d throughout the dosing period.

Normal morphological nature of vital organs indicated that the extract did not affect their metabolism adversely (Table 4). Statistically analyzed data between control versus all three treated groups showed no significant variation in liver (4.03±0.21 to 4.10±0.05 g), kidney (0.74±0.04 to 0.73±0.06) and heart (0.31±0.02 to 0.27±0.02), weight (p>0.05), but there was a significant decrease in brain weight (p<0.01) of group IV animals (0.68±0.06) compared to control group (0.80±0.02). However, no significant variations were observed in Hemoglobin (Hb) content (14.25±0.78 to 15.33 ±1.07 mg %), Red Blood Cells (RBC) (7.65±0.21 to 6.54±0.23 103/mm3), total and differential White Blood Cells (WBC) counts (8850.00±954.50 to 7766.67±1942.51 cells/mm3) and platelet counts (7.75±0.35 to 8.37±0.78 105/mm3) in all three treated groups (p>0.05) compared to control group (Table 5).

Treatments Liver Kidney Heart Brain
Control 4.03±0.21 0.74±0.04 0.31±0.02 0.80±0.02
25 mg/kg 4.06±0.21 0.70±0.00 0.31±0.02 0.73±0.02
50 mg/kg 3.84±0.08 0.69±0.08 0.31±0.00 0.74±0.03
100 mg/kg 4.10±0.05 0.73±0.06 0.27±0.02 0.68±0.06*

Table 4: Relative Organ Weight of Control and Treated Groups

Parameters Group I (Control) Group II (25 mg/kg) Group III (50 mg/kg) Group IV (100 mg/kg)
Hb (g %) 14.25±0.78 14.85±0.64 15.10±1.15 15.33±1.07
RBC (103/mm3) 7.65±0.21 7.39±0.29 7.44±0.37 6.54±0.23
Mean corpuscular volume (MCV) (fl) 61.90±1.27 60.65±0.21 59.73±1.19 60.73±0.75
Mean corpuscular hemoglobin (MCH) (pg) 19.05±1.06 20.05±0.07 20.23±0.51 20.63±0.84
Mean corpuscular hemoglobin concentration (MCHC) (g/dl) 30.55±2.05 33.15±0.21 33.93±0.40 34.07±0.91
Hematocrit (HCT)-packed cell volume (PCV) (%) 46.05±1.48 45.00±1.41 44.67±3.06 45.00±2.00
Platelets (105/mm3) 7.75±0.35 7.28±0.02 7.47±0.70 8.37±0.78
WBC (cells/mm3) 8850±954 8750±606 9333±312 7766±425
Neutrophils (%) 27.50±3.54 23.50±0.71 17.33±3.06 17.67±7.23
Lymphocytes (%) 70.50±2.12 69.00±1.41 75.67±2.89 73.67±6.51
Eosinophils (%) 2.00±0.00 7.5±0.71 7.00±1.00 8.67±2.89

Table 5: Effect of Seed Extract on Haemogram Profile

Proper functioning of the liver was assayed by various enzyme markers such as SGOT, SGPT and ALP that were present in the serum (Table 6). Results showed an insignificant increase in the serum SGOT level of group IV animals (110.67±9.02 U/l), however, the values were within the normal reference levels. No significant changes were observed in SGPT (59.00±4.24 to 46.33±9.02 U/l) and ALP (480.50±9.19 to 434.67±49.17 U/l) levels of treated groups (p>0.05) when compared with group I (control). Similarly, there was no change in total protein (7.30±0.14 to 7.60±0.52 g/dl) and bilirubin levels (0.50±0.00 to 0.43±0.15 mg/dl) in the treated groups (p>0.05) and an undisturbed albumin globulin ratio was observed in all treated groups.

Parameters Group I (Control) Group II (25 mg/kg) Group III (50 mg/kg) Group IV (100 mg/kg)
SGOT (U/L) 69.00±9.90 98.00±35.36 85.00±12.12 110.67±9.02
SGPT (U/L) 59.00±4.24 46.50±19.09 45.67±5.13 46.33±9.02
ALP (U/L) 480.50±9.19 428.00±45.96 403.00±87.02 434.67±49.17
Total protein (g/dl) 7.30±0.14 7.40±0.00 7.57±0.40 7.60±0.52
Albumin (g/dl) 4.25±0.07 4.45±0.07 4.70±0.36 4.63±0.49
Globulin (g/dl) 3.30±0.42 2.95±0.07 2.87±0.06 2.97±0.06
Bilirubin, total (mg/dl) 0.50±0.00 0.45±0.07 0.43±0.16 0.43±0.15
Bilirubin direct (mg/dl) 0.2±0.00 0.15±0.07 0.13±0.06 0.13±0.06
Bilirubin indirect (mg/dl) 0.3±0.00 0.30±0.00 0.30±0.00 0.30±0.00

Table 6: Effect of Seed Extract on Liver Functioning Enzymes in Serum

Renal functioning was assayed by estimating the level of creatinine and urea in blood serum (Table 7). There were no statistically significant differences in urea level of treated animal groups (31.50±2.12 to 33.00 ±6.56 mg/dl), but the slight decrease observed in creatinine level of group II and III (0.49±0.06 and 0.48±0.06 mg/dl) when compared with control (0.65±0.07) were found as statistically insignificant (p>0.05).

Parameters Group I (Control) Group II (25 mg/kg) Group III (50 mg/kg) Group IV (100 mg/kg)
Creatinine (mg/dl) 0.65±0.07 0.55±0.07 0.49±0.06 0.48±0.06
Urea (mg/dl) 31.50±2.12 32.00±9.90 30.67±3.21 33.00±6.56

Table 7: Effect of Seed Extract on Renal Profile

There was no statistically significant difference between the groups of all treated groups against the control animals in total cholesterol level, triglycerides, High-Density Lipoprotein (HDL), Very Low-Density Lipoprotein (VLDL) and low-density lipoprotein (LDL) (p>0.05). The level of serum electrolytes (sodium (Na), potassium (K), chloride and bicarbonates) was found unaltered (Table 8) in the treated groups significantly (p>0.05). The normal level of these electrolytes was represented as 143.70±1.84, 7.40±0.28 and 24.50 ±0.71 mmol/l and higher dosage animals (100 mg/kg) recorded 140.83±3.41, 5.22±0.78 and 23.00 ±1.00 mmol/l respectively (Table 9). The chloride level in serum was also found to be unaltered and represented by 98.70±0.99 (control group) to 93.55±1.34, 93.71±1.18 and 93.03±1.04 in all three treated groups correspondingly.

Parameters Group I (Control) Group II (25 mg/kg) Group III (50 mg/kg) Group IV (100 mg/kg)
   Total cholesterol (mg/dl) 87.00±7.07 85.5±6.36 88.33±9.87 92.33±14.01
Triglycerides (mg/dl) 61.00±4.24 72.00±11.31 75.67±5.69 78.67±10.97
HDL (mg/dl) 24.50±3.54 23.50±0.71 22.67±0.58 24.00±1.00
LDL (mg/dl) 45.50±3.54 47.50±3.54 50.67±9.45 52.67±12.50
VLDL (mg/dl) 13.00±1.41 14.50±2.12 15.00±1.00 15.67±2.31

Table 8: Effect of Seed Extract on Lipid Profile

Parameters Group I (Control) Group II (25 mg/kg) Group III (50 mg/kg) Group IV (100 mg/kg)
Na (mmol/l) 143.70±1.84 137.80±1.84 140.10±2.14 140.83±3.41
K (mmol/l) 7.40±0.28 5.51±1.36 6.02±0.86 5.22±0.78
Cl (mmol/l) 96.70±3.81 93.55±1.34 93.71±1.18 93.03±1.04
Bicarbonate (HCO3) (mmol/l) 24.50±0.71 24.50±0.71 22.67±0.58 23.00±1.00

Table 9: Effect of Seed Extract on Serum Electrolytes

Toxicity is the relative ability of a substance to cause injury to biologic tissues [16]. Studies were conducted to determine the safety and efficacy levels, the lethal dose and related metabolic alterations and pharmacological manifestations using acute and subacute guidelines of the OECD.

Animals treated with a single dose of extract (500 mg/kg) caused 100 % mortality than the preceding group (250 mg/kg) which showed no mortality rates, but experienced a reduction in body weight, food consumption and water intake. However, lower dosed animals (100 mg/kg) showed normal behavior, similar to the control group. Lethality (LD50) associated with 70 % MT extract was calculated as 375 mg/kg, revealed the narrow margin of safety lies in between 250 and 500 mg/kg, on seed intake either in raw form or in processed form.

The toxic nature of seeds was further revealed by various researchers. Enriquez et al. [17] observed a lethal dose (LD50) of 447 mg/kg in mice after milled seed administration and Taiwo et al. [18] reported 100 % mortality in rabbits within 14 d, after 10 % raw seed administration. Moreover, a lower lethal dose of 507 mg/kg with a concentrated aqueous kernel extract and higher dose of 5700 mg/kg with the bait formulated using 40 % of the kernel meal was observed in albino rats [19], with severe clinical malfunctioning [20]. But, the human mortality associated with oleander ingestion is generally very low, even in cases of intentional consumption (suicide attempts) [21] and surprisingly in Mexico, the seeds are widely used to reduce body weight [17].

After determining the lethal level via acute dosage, subacute experiments were carried out for 14 d of regular oral drug exposure. Since 500 mg/kg produced severe toxicity symptoms with 100 % lethality (LD100), for subacute studies a dose level of 1/20th, 1/10th and 1/5th (25, 50 and 100 mg/kg) was selected. The selected doses neither affected body weight nor food consumption and water intake. Adverse reactions often resulted from excess dosage effects of any ‘active principles’ [1].

Normal values of haematological parameters (RBC, WBC and platelets), lipid profiling (cholesterol, triglycerides) and serum electrolytes (Na, K) are related to the proper metabolism of the endocrine system. Treatment of rats with different doses of the seed kernel extract did not alter the serum marker enzymes in liver (SGOT, SGPT, ALP) and kidney (creatinine, urea), indicated the absence of hepatocellular and nephrocellular necrosis, as elevated levels of blood serum enzymes are indicative of cellular leakage, necrosis and loss of functional integrity of cell membranes [22]. The normal morphological behavior of vital organs was concurrent with liver and kidney function tests, which showed normal values in all groups under study, including the highest dose (100 mg/kg) of administration. However, leaf extract of Nerium oleander, a close relative of yellow oleander, showed significant adverse changes in haematological, biochemical and inflammatory parameters, as well as histopathological alterations in heart and liver tissues [23].

Albumin is one of the key components of serum protein. As albumin is synthesized in the liver, it can be used as a biomarker to monitor liver functions. Serum bilirubin and total protein levels are also related to the functions of hepatic cells. In the present study normal albumin, globulin and bilirubin levels are considered as nondisturbances in protein synthesis in the liver, confirmed the proper functioning of this organ.

In the acute toxicity experiment, a single dose of 500 mg/kg produced 100 % lethality, but the absence of any clinical manifestations after a cumulative dose of 1400 mg/kg administered for 14 consecutive days, reflect the detoxification/purification processes carried out by the liver and kidney. The liver is expected not only to perform physiological functions, but also to protect against the hazards of harmful drugs and chemicals [24] by detoxifying most of the components that enter the body [25], while the kidney is a principal route of excretion of many chemical substances in their active and/or inactive forms [26]. It is generally accepted that the paramount organ for degradation of cardiotonic steroids is the liver. A significant hepatoprotective activity as well as considerable antioxidant properties was reported by Singhal and Gupta, [27] in flower extracts of Nerium oleander, a close relative of ‘yellow oleander’[28].

With the words of Paracelsus (1493-1541) “All substances are poisons; there is none which is not a poison. The right dose differentiates a poison and a remedy”, the following conclusions were drawn after toxicity studies of ‘yellow oleander’ seed kernel extracts. Acute studies revealed that 70 % MT seed extract showed LD50 at 375 mg/kg body weight and a single oral dose of 500 mg/kg showed 100 % lethality revealed a narrow margin of safety. Similarly, a single sub-lethal dose (250 mg/kg) reduced body weight and affected feeding habits. But, a repeated dosage of 100 mg/kg for consecutive 14 d did not affect the normal physiology, metabolism and biochemistry of experimental Wistar rats.


The first author is thankful to University Grants Commission for supporting to complete Ph. D work and Amala Cancer Research Institute for carrying out animal studies.

Conflict of interests

The authors declared no conflict of interest.